281 related articles for article (PubMed ID: 23916459)
1. A literature review on cardiovascular risk in human immunodeficiency virus-infected patients: implications for clinical management.
Neto MG; Zwirtes R; Brites C
Braz J Infect Dis; 2013; 17(6):691-700. PubMed ID: 23916459
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular toxicity with highly active antiretroviral therapy: review of clinical studies.
Bozkurt B
Cardiovasc Toxicol; 2004; 4(3):243-60. PubMed ID: 15470272
[TBL] [Abstract][Full Text] [Related]
3. Association between protease inhibitor use and increased cardiovascular risk in patients infected with human immunodeficiency virus: a systematic review.
Rhew DC; Bernal M; Aguilar D; Iloeje U; Goetz MB
Clin Infect Dis; 2003 Oct; 37(7):959-72. PubMed ID: 13130409
[TBL] [Abstract][Full Text] [Related]
4. [Metabolic and cardiovascular effects of combined antiretroviral therapy in patients with HIV infection. Systematic review of literature].
Casaretti L; Paolillo S; Formisano R; Bologna A; Mattiello G; Conte S; Petraglia L; Lo ludice F; Fabiani I; Cirillo AP; Vitagliano A; Gambardella F; della Ratta GL; Filardi PP
Monaldi Arch Chest Dis; 2011 Dec; 76(4):175-82. PubMed ID: 22567733
[TBL] [Abstract][Full Text] [Related]
5. [HIV infection, antiretroviral therapy, and endothelium].
Hürlimann D; Weber R; Enseleit F; Lüscher TF
Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
[TBL] [Abstract][Full Text] [Related]
6. Management of metabolic complications and cardiovascular risk in HIV-infected patients.
Blanco F; San Román J; Vispo E; López M; Salto A; Abad V; Soriano V
AIDS Rev; 2010; 12(4):231-41. PubMed ID: 21179187
[TBL] [Abstract][Full Text] [Related]
7. Dyslipidemia related to antiretroviral therapy.
Estrada V; Portilla J
AIDS Rev; 2011; 13(1):49-56. PubMed ID: 21412389
[TBL] [Abstract][Full Text] [Related]
8. HIV and antiretroviral therapy: lipid abnormalities and associated cardiovascular risk in HIV-infected patients.
Kotler DP
J Acquir Immune Defic Syndr; 2008 Sep; 49 Suppl 2():S79-85. PubMed ID: 18725816
[TBL] [Abstract][Full Text] [Related]
9. Highly active antiretroviral therapy-associated metabolic syndrome and cardiovascular risk.
Barbaro G; Barbarini G
Chemotherapy; 2006; 52(4):161-5. PubMed ID: 16675900
[TBL] [Abstract][Full Text] [Related]
10. Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy.
Calza L; Manfredi R; Pocaterra D; Chiodo F
J Infect; 2008 Jul; 57(1):16-32. PubMed ID: 18358535
[TBL] [Abstract][Full Text] [Related]
11. Systemic and cell-specific mechanisms of vasculopathy induced by human immunodeficiency virus and highly active antiretroviral therapy.
Haser GC; Sumpio B
J Vasc Surg; 2017 Mar; 65(3):849-859. PubMed ID: 26994951
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral therapy with heart.
Randell P; Moyle G
Am J Ther; 2009; 16(6):579-84. PubMed ID: 19940610
[TBL] [Abstract][Full Text] [Related]
13. Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection.
Barbaro G
Curr HIV Res; 2006 Jan; 4(1):79-85. PubMed ID: 16454713
[TBL] [Abstract][Full Text] [Related]
14. Reviewing the cardiovascular complications of HIV infection after the introduction of highly active antiretroviral therapy.
Barbaro G
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Aug; 5(4):337-43. PubMed ID: 16101566
[TBL] [Abstract][Full Text] [Related]
15. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents.
Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
Ann Intern Med; 2002 Sep; 137(5 Pt 2):381-433. PubMed ID: 12617573
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral therapy in HIV-infected children: the metabolic cost of improved survival.
Leonard EG; McComsey GA
Infect Dis Clin North Am; 2005 Sep; 19(3):713-29. PubMed ID: 16102657
[TBL] [Abstract][Full Text] [Related]
17. [Coronary heart disease associated with the use of highly active antiretroviral therapy (HAART). A case report and review].
Neumann T; Kondratieva J; Eggebrecht H; Wieneke H; Esser S; Bartel T; Erbel R
Herz; 2005 Sep; 30(6):504-9. PubMed ID: 16170681
[TBL] [Abstract][Full Text] [Related]
18. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.
Dybul M; Fauci AS; Bartlett JG; Kaplan JE; Pau AK;
MMWR Recomm Rep; 2002 May; 51(RR-7):1-55. PubMed ID: 12027060
[TBL] [Abstract][Full Text] [Related]
19. [A decade of antiretroviral therapy: a profile of patients with 10 years of highly effective triple therapy].
Wilson G; Wolff M
Rev Chilena Infectol; 2012 Jun; 29(3):337-43. PubMed ID: 23096476
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus.
Grinspoon SK
Am J Med; 2005 Apr; 118 Suppl 2():23S-28S. PubMed ID: 15903292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]